CompuGroup Medical SE & Co. KGaA
CMPVFOTCHealthcare
$33.66
+$3.51(+11.64%)
Market Cap$1.7B
P/E Ratio—
52W High$33.66
52W Low$30.15
CompuGroup Medical SE & Co. KGaA (CMPVF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CMPVF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.21B | $1.15B | $1.19B | $1.12B | $1.03B |
| Cost of Revenue | $0.98B | $0.19B | $0.18B | $0.78B | $0.74B |
| Gross Profit | $0.23B | $0.97B | $1.01B | $0.34B | $0.29B |
| Gross Margin %(computed) | 18.79% | 83.64% | 84.62% | 30.51% | 27.88% |
| Operating Expenses | |||||
| R&D Expenses | $0.27B | $0.00B | $0.03B | $0.01B | $0.09B |
| G&A Expenses | $0.00B | $0.03B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.14B | $0.86B | $0.14B | $0.03B | $0.11B |
| Operating Income | $0.09B | $0.11B | $0.12B | $0.13B | $0.12B |
| Operating Margin %(computed) | 7.55% | 9.16% | 10.35% | 11.21% | 12.00% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.04B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.06B | $0.06B | $0.07B | $0.11B | $0.09B |
| Income Tax Expense | $0.03B | $0.03B | $0.03B | $0.03B | $0.03B |
| Net Income | $0.03B | $0.03B | $0.04B | $0.07B | $0.06B |
| Net Margin %(computed) | 2.33% | 3.00% | 3.51% | 6.07% | 5.92% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.54 | $0.67 | $0.88 | $1.39 | $1.32 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | $0.20B | $0.21B | $0.19B | $0.22B | $0.20B |
| EBITDA Margin %(computed) | 16.34% | 17.93% | 16.28% | 19.53% | 19.66% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more CompuGroup Medical SE & Co. KGaA data
About CompuGroup Medical SE & Co. KGaA (CMPVF) Income Statement
CompuGroup Medical SE & Co. KGaA (CMPVF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CMPVF reported revenue of $1.21B, gross profit of $0.23B (gross margin 18.79%), and net income of $0.03B — a net profit margin of 2.33%.
Frequently asked questions
CMPVF · 4 questionsCompuGroup Medical SE & Co. KGaA (CMPVF) reported revenue of $1.21B for 2025, up 5.1% year-over-year.
CMPVF revenueCMPVF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08